Producción científica
Buscar por:
Lista de artículos
| Publicación |
|
Y. Sixto López, C. Ordaz-Pichardo, J.A. Gómez Vidal, M.C. Hernández -Rosales
and
J. Correa-Basurto,
"Cytotoxic evaluation of YSL-109 in a triple negative breast cancer cell line and toxicological evaluations", "Naunyn-Schmiedeberg's Archives of Pharmacology"
, -, 2023
|
|
Y. Sixto López
and
J. Correa-Basurto,
"HDAC inhibition as neuroprotection in COVID-19 infection", "Current Topics in Medicinal Chemistry"
, -, 2022
|
|
F. Arias Bordajandi, M.E. Camacho-Quesada
and
M.D. Carrión Peregrina,
"NMR spectroscopy study of new imidamide derivatives as nitric oxide synthase inhibitors", "Magnetic Resonance in Chemistry"
, -, 2022
|
|
I. Balbuena-Rebolledo, A.M. Rivera-Antonio, Y. Sixto López, J. Correa-Basurto, M.C. Rosales-Hernández, J.E. Mendieta-Wejebe, F.J. Martínez-Martínez, I.M. Olivares-Corichi, J.R. García-Sánchez, J.A. Guevara-Salazar, M. Bello
and
I.I. Padilla-Martínez,
"Dihydropyrazole-Carbohydrazide Derivatives with Dual Activity as Antioxidant and Anti-Proliferative Drugs on Breast Cancer Targeting the HDAC6", "Pharmaceuticals"
, vol.15, 1-23, 2022
|
|
P. Garcia -Molina, A. Sola Leyva, P.M. Luque Navarro, A. Laso, P. Ríos-Marco, A. Ríos Guadix, D. Lanari, A. Torretta, E. Parisini, L.C. Lopez Cara, C. Marco De La Calle
and
M.P. Carrasco Jimenez,
"Anticancer Activity of the Choline Kinase Inhibitor PL48 Is Due to Selective Disruption of Choline Metabolism and Transport Systems in Cancer Cell Lines", "Pharmaceutics"
, vol.14, 426-, 2022
|
|
A. Alejo-Armijo, C. Cuadrado, J. Altarejos-Caballero, M.X. Fernandes, E. Salido-Ruiz, M. Díaz Gavilán
and
S. Salido,
"Lactate dehydrogenase A inhibitors with a 2,8-dioxabicyclo[3.3.1]nonane scaffold: A contribution to molecular therapies for primary hyperoxalurias", "Bioorganic Chemistry"
, vol.129, 106127-, 2022
|
|
G. Raja, G. Venkatesh, J.S. Al-Otaibi, P. Vennila, Y. Sheenamary
and
Y. Sixto López,
"Synthesis, Characterization, Molecular Docking and Molecular Dynamics Simulations of Benzamide Derivatives as Potential Anti-Ovarian Cancer Agents", "Journal of Molecular Structure"
, vol.1269, 1-15, 2022
|
|
P.M. Luque Navarro, E. Mariotto, M. Ballarotto, G. Rubbini, F.J. Aguilar-Troyano, A. Fasiolo, A. Torretta, E. Parisini, A. Macchiarulo , A. Laso, C. Marco De La Calle, G. Viola, M.P. Carrasco Jimenez
and
L.C. Lopez Cara,
"Biological Evaluation of New Thienopyridinium and Thienopyrimidinium Derivatives as Human Choline Kinase Inhibitors", "Pharmaceutics"
, vol.14, 715-, 2022
|
|
|
Última actualización del SICA: 30/04/2025
julio 2025
ANTERIOR